Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer

Petrylak, Daniel P; Tangen, Catherine M; Hussain, Maha H.A.; Lara, Primo N; Jones, Jeffrey A; Taplin, Mary Ellen; Burch, Patrick A; Berry, Donna E.; Moinpour, Carol M; Kohli, Manish; Benson, Mitchell C.; Small, Eric J; Raghavan, Derek; Crawford, E David

doi:10.1056/NEJMOA041318

Record: found
Abstract: found
Article: not found

Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer

journal-article

Author(s): Daniel P. Petrylak , Catherine M. Tangen , Maha H.A. Hussain , Primo N. Lara , Jeffrey A. Jones , Mary Ellen Taplin , Patrick A. Burch , Donna Berry , Carol Moinpour , Manish Kohli , Mitchell C. Benson , Eric J. Small , Derek Raghavan , E. David Crawford

Publication date (Electronic): 2004

Publisher: Massachusetts Medical Society

Read this article at

ScienceOpenPublisher PubMed

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

New England Journal of Medicine, 351(15), 1513-1520

Related collections

Author and article information

Journal

Publisher: Massachusetts Medical Society

Publication date (Electronic): 2004

Publication date (Issued): 07 October 2004

Publication date Updated: 06 September 2018

Article

DOI: 10.1056/NEJMOA041318

PubMed ID: 15470214

SO-VID: 1e40341b-2764-4ef4-8a0a-73f897163485

History

Data availability:

Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer

Read this article at

Abstract

Related collections

Online interactive cancer simulations and demos

Author and article information

Journal

Article

History

Comments

Comment on this article

Cited by 705